The Potential Relevance to the United States of the European Union's Newly Adopted Regulatory Framework for Telecommunications

被引:0
|
作者
Marcus, J. Scott
机构
关键词
D O I
暂无
中图分类号
G2 [信息与知识传播];
学科分类号
05 ; 0503 ;
摘要
引用
收藏
页码:397 / 428
页数:32
相关论文
共 50 条
  • [1] The agricultural subsidies in international trade: the policies adopted by the European Union and the United States of America
    Rodrigues Bruno, Flavio Marcelo
    Zago de Azevedo, Andre Filipe
    Massuquetti, Angelica
    [J]. CIENCIA RURAL, 2012, 42 (04): : 757 - 764
  • [2] New regulatory framework for telecommunications in the European Community
    Cordaro, G.
    [J]. British Telecommunications Engineering, 1990, 9 : 28 - 31
  • [3] A NEW REGULATORY FRAMEWORK FOR TELECOMMUNICATIONS IN THE EUROPEAN COMMUNITY
    CORDARO, G
    [J]. BRITISH TELECOMMUNICATIONS ENGINEERING, 1990, 9 : 28 - 31
  • [5] The United States and the European Union
    不详
    [J]. AMERICAN FOREIGN POLICY INTERESTS, 2005, 27 (06) : 531 - 533
  • [6] Regulatory framework for plasmapheresis in the European Union: Industry's viewpoint
    Pisani, E
    [J]. HEMATOLOGY AND CELL THERAPY, 1996, 38 : S35 - S38
  • [7] The regulatory framework of biosimilars in the European Union
    Minghetti, Paola
    Rocco, Paolo
    Cilurzo, Francesco
    Del Vecchio, Lucia
    Locatelli, Francesco
    [J]. DRUG DISCOVERY TODAY, 2012, 17 (1-2) : 63 - 70
  • [8] THE IMPACT OF EUROPEAN UNION'S NEWLY-ADOPTED ENVIRONMENTAL STANDARDS ON ITS TRADING PARTNERS
    Burnete, Sorin
    Choomta, Pilasluck
    [J]. STUDIES IN BUSINESS AND ECONOMICS, 2015, 10 (03) : 5 - 15
  • [9] Comparison of regulatory pathways for the approval of advanced therapies in the European Union and the United States
    Iglesias-Lopez, Carolina
    Obach, Merce
    Vallano, Antonio
    Agusti, Antonia
    [J]. CYTOTHERAPY, 2021, 23 (03) : 261 - 274
  • [10] Regulatory Approval Scenario of Biosimilars in Pediatric Patients in the United States and European Union
    Swetha Radhakrishna
    Meghana Dahiya
    Parag Pipalava
    Vinu Jose
    [J]. Pharmaceutical Medicine, 2021, 35 : 93 - 112